We need combination treatments to help win the fight against cancer.
Cancer is made up of more than 200 different diseases, many of which are too complex to tackle with single drug treatments. Patients deserve more than lottery odds of finding the right combinations.
About Us
KYAN’s mission is to unlock the full potential of combination therapies, addressing unmet needs where monotherapies and single target development efforts fail.
RATIONAL
From years of research and validation, we have crafted a streamlined approach to find safe and effective combinations from endless possibilities.
Our patented computational methodology works to overcome low success rates and the soaring costs of combination development based on serendipity, convenience, and incomplete knowledge.
RELEVANT
We use data from efficiently designed experiments. For each case, we ask the question: What is the best combination? We obtain a faster, more accurate answer by looking at prospective data rather than sifting through mounds of information that already exists and is mostly irrelevant.
REAL
We validate our results against disease models from in vitro to human. Our platform has been used for successful interventional combination treatment for real-life patients.

OPTIM.AI PLATFORM
Combination Design

Prioritization

Dosage Optimization

Precision Medicine

News
KYAN Therapeutics Announces Collaboration with Institute of Molecular and Cell Biology for Accelerated Drug Discovery and Development of Nucleic Acids
We have entered into a collaboration with Institute of Molecular and Cell Biology to discover and develop next-generation nucleic acid […]
KYAN Therapeutics Exclusively Licenses Small Molecule
We acquired the rights to develop promising HDAC inhibitors for AI-powered cancer drug development. Read more in our press release: […]
AI Platform Aids Treatment for Relapsed Lymphoma
An application of our technology was recently featured in The Straits Times. You can read more about it here: https://www.straitstimes.com/singapore/ai-platform-aids-treatment-for-relapsed-lymphoma.
RECENT PUBLICATIONS
Bioengineering and Translational Medicine
Science
Artificial intelligence in cancer therapy
Blood Cancer Journal
Advanced Therapeutics
Science Translational Medicine
Our Team Members
Our Advisors
Partners and Collaborators
Contact Us
We are passionate about what we do and if you have any interesting projects and ideas to share with us, feel free to send us an email or drop us a message in the contact form to the right.
Email: contact@kyantherapeutics.com